The resolution designates the last Tuesday of each April as APOL1-Mediated Kidney Disease (AMKD) Awareness Day in Alabama. This initiative aims to raise awareness about AMKD and other types of kidney diseases, particularly among individuals of Western and Central African ancestry, who are at a higher risk due to genetic factors associated with the APOL1 gene. The resolution highlights the significant disparity in kidney disease prevalence among African Americans, who represent a disproportionate percentage of kidney failure cases in the United States. It emphasizes the importance of genetic testing and encourages individuals to become informed about their health risks.

Furthermore, the resolution calls for increased public awareness and understanding of AMKD, which can lead to early diagnosis and better management of the disease. It outlines the potential health benefits of regular medical consultations, a healthy lifestyle, and adherence to prescribed treatments for those with APOL1 genetic variants. While there are currently no approved treatments targeting the underlying causes of APOL1-mediated kidney disease, the resolution supports ongoing research and clinical trials aimed at developing effective therapies. The legislature encourages all Alabama citizens to participate in efforts to improve treatment options and seek a cure for this condition.